This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. New York fitness trainer and gym owner Kenny Santucci discusses concerns about unverified peptide products for muscle building, saying consumers should work with physicians. A new weight-loss drug variation is showing promise in early trials. Research from the Institute for Diabetes and Obesity at Helmholtz Munich in Germany, published in the journal Nature, tested an experimental obesity and diabetes drug called GLP-1-GIP-Lani. The drug combines GLP-1 and GIP — two natural hormones that help regulate appetite and blood sugar, similar to popular weight-loss drugs like Ozempic — with PPAR activity, which may improve insulin sensitivity, inflammation, fat metabolism and liver health. 'NEXT OZEMPIC' AIMS TO DELIVER 30% WEIGHT LOSS WITH FEWER SIDE EFFECTS The team of researchers, led by Professor Timo D. Muller at Helmoltz Munich, called the drug a quint
May 14, 2026 → May 16, 2026
GLP-1 weight loss jabs have become one of the biggest medical stories of the decade. About 100 million people are on them worldwide, according to the World Health Organization, and with the University College London estimating that number…
Read original at BBC →2 updates from 2 sources over 2 days.
GLP-1 weight loss jabs have become one of the biggest medical stories of the decade. About 100 million people are on them worldwide, according to the World Health Organization, and with the University College London…
Read original at BBC →This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by…
Read original at Fox News →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
GLP-1 weight loss jabs have become one of the biggest medical stories of the decade. About 100 million people are on them worldwide, according to the World Health Organization, and with the University College London estimating that number…
View source →This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Shares in Spire Healthcare jump after approach from Toscafund, founded by City figure known as âthe Rottweilerâ The board of Britainâs largest private hospital operator has…
This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least…
Merged institution will become second largest mainstream university in UK with about 47,000 students Kingâs College London has agreed to merge with Cranfield University,…
Research led by WHO predicts hotter climate will lead to more contact between humans and venomous snakes The risk of snakebites is increasing across the world as reptiles shift…
The Netherlands is arguably the strongest footballing nation never to have won a World Cup When Paul the Octopus predicted all of Germany's results correctly at the 2010 World…
The World Health Organization on Sunday declared an Ebola outbreak in the Democratic Republic of Congo and Uganda a âpublic health emergency of international concern,â posing…
